---
name: Pilot Patient SR Age 30

data:
- 
  resourceType: Patient
  name: Selena45 Richardson40
  gender: female
  birthDate: 1993-06-01
  extension:
  -
    url: http://hl7.org/fhir/us/core/StructureDefinition/us-core-birthsex
    valueCode: F

# CIN1 CIN2 Colposcopy
-
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - SNOMEDCT#285836003 Cervical intraepithelial neoplasia grade 1 (disorder)
  - SNOMEDCT#285838002 Cervical intraepithelial neoplasia grade 2 (disorder)
  effectiveDateTime: 2023-04-07
-
  resourceType: Procedure
  code: CPT#57455 Colposcopy of the cervix including upper/adjacent vagina; with biopsy(s) of the cervix
  performedDateTime: 2023-04-07
  status: completed

# Colposcopy OTHER
# No biopsy taken (patient pregnant at the time)
# Don't know if there is an empty diagnostic report in patient record for this?

-
  resourceType: DiagnosticReport
  code: LOINC#65753-6 Cervix Pathology biopsy report
  status: final
  conclusionCode:
  - NULL FLAVOR#UNK Unknown
  effectiveDateTime: 2022-11-17
-
  resourceType: Procedure
  code: CPT#57455 Colposcopy of the cervix including upper/adjacent vagina; with biopsy(s) of the cervix
  performedDateTime: 2022-11-17
  status: completed

# LSIL
- 
  resourceType: DiagnosticReport
  code: LOINC#47527-7 Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep
  status: amended
  conclusionCode:
  - SNOMEDCT#62051000119105 Low grade squamous intraepithelial lesion on cervical Papanicolaou smear (finding)
  effectiveDateTime: 2023-09-07


results:
  HasRecentAbnormalScreening: true
  ManagementRecommendation: 
    short: 'Surveillance or Treatment'
    date: '2023-12-30'
    group: 'Managing Histology (I.2)'
    details:
    - "Treatment of CIN2 is recommended unless the patient's concerns about the effect of treatment on future pregnancy outweigh concerns about cancer."
    - 'Excisional treatment is preferred, and treatment with ablation is acceptable.'
    - 'Observation is unacceptable when the squamocolumnar junction or the upper limit of the lesion is not fully visualized or when the results of an endocervical sampling, if performed, is CIN 2+ or ungraded.'
    - 'Observation includes colposcopy and primary hrHPV testing or cotesting at 6-month intervals for up to 2 years.'
  